DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS Russian patent published in 2006 - IPC C07D471/04 C07D471/14 C07D491/14 C07D495/14 A61K31/437 A61P15/00 

Abstract RU 2267490 C2

FIELD: organic chemistry, biochemistry, medicine, pharmacy.

SUBSTANCE: invention describes a compound of the general formula (I) or (II) wherein R1 represents hydrogen atom; R2 is taken among the group consisting of aryl and heteroaryl; R3 is taken among the group consisting of halogen atom, nitro-, cyano-group, (C1-C6)-alkyl, (C1-C6)-alkoxy-group, trifluoromethyl, trifluoromethoxy-group, -NH2, -NH-(C1-C6)-alkyl and -N-(C1-C6)-alkyl)2; b is a whole number from 0 to 4; R4 is taken independently among the group consisting of halogen atom, hydroxy-, carboxy-, oxo-group, (C1-C6)-alkyl, (C1-C6)-alkoxy-group, (C1-C6)-alkoxycarbonyl, phenyl (wherein phenyl group can be substituted optionally with one-three substitutes taken independently among RD), phenylsulfonyl, heteroaryl (wherein heteroaryl can be substituted optionally with one-three substitutes taken independently among RD), heterocycloalkyl, -NH2, -NHRA, -N-(RA)2,

wherein each RD is taken independently among halogen atom, hydroxy-, carboxy-, oxo-group, (C1-C4)-alkyl, (C1-C4)-alkylthio, hydroxy-(C1-C4)-alkyl, (C1-C4)-alkoxy-group, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylcarbonyl, trifluoromethyl, trifluoromethoxy-group, -NH2. -NHRA, -N-(RA)2, -C(O)N(RA)2, -SO2N(RA)2, acetylamino-, nitro-, cyano-group, formyl, (C1-C6)-alkylsulfonyl, carboxy-(C1-C6)-alkyl and aralkyl; c = 0; a means a whole number from 0 to 1; Y is taken among the group consisting of a residue -(C1-C)-alkyl, -C(O)-, -(C2-C6)-alkenyl)-carbonyl, -carbonyl-(C1-C6)-alkyl)-, -C(S)-, -C(O)NH-(C1-C6)_alkyl), -C(O)-(C3-C7)-cycloalkyl)- and (C3-C7)-cycloalkyl)-C(O)-; represents phenyl;

is taken among the group consisting of phenyl, heteroaryl and cycloalkyl under condition that when R1 represents hydrogen atom, R3 represents hydrogen atom, b = 0, c = 1, Y represents -CH2-, represents phenyl and represents phenyl then R2 is not trimethoxyphenyl, and its pharmaceutically acceptable salts. Also, invention describes a pharmaceutical composition designated for inhibition of activity of phosphodiesterase comprising a pharmaceutically acceptable vehicle and compound by cl. 1, method for preparing pharmaceutical composition, methods for treatment of sexual dysfunction by using compound by cl. 1 or pharmaceutical composition, method for increasing the concentration of cGMP in penis tissue and method for treatment of state when inhibition of activity of phosphodiesterase shows the favorable effect. Invention provides preparing novel compounds possessing useful biological properties.

EFFECT: valuable medicinal and biochemical properties of compounds and composition.

17 cl, 7 tbl, 98 ex

Similar patents RU2267490C2

Title Year Author Number
DERIVATIVES OF BETA-CARBOLINE POSSESSING EFFECT OF PHOSPHODIESTERASE INHIBITORS, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ITS PREPARING, METHOD FOR INHIBITION OF PHOSPHODIESTERASE EFFECT (VARIANTS) AND METHOD FOR INCREASING CGMP CONCENTRATION 2001
  • Sui Zikhua
  • Makajlehg Mark Dzh.
RU2271358C2
SUBSTITUTED PYRIMIDINETHIOALKYL OR ALKYLESTER COMPOUNDS AND METHOD OF INHIBITION OF VIRAL REVERSE TRANSCRIPTASE ACTIVITY 1996
  • Richard A. N'Judzhent
  • Donn G. Vishka
  • Gari Dzh. Klik
  • Dehvid R. Grejber
  • Stiven Tomas Shljakhter
  • Majkl Dzh. Merfi
  • Dzhoel Morris
  • Richard S. Tomas
RU2167155C2
N-HYDROXY-BENZAMIDES FOR TREATING CANCER 2011
  • Go Le
  • Tan Gochzhi
  • Van Chzhango
  • Von Dzhejson Kristofer
  • Chzhan Vejsin
RU2577861C2
THIENOPYRIMIDNEDIONES, METHODS FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION 2002
  • Rejnolds Rejchel Kh'Juluehn
  • Ingoll Ehtoni Khauard
  • Rehjsul Rakhsehjna Tehsnim
  • Gil Sajmon Dejvid
  • Kuper Martin Ehdvard
RU2294937C9
KINASE INHIBITORS 2013
  • Alkara, Lilian
  • Panchal, Terri Aaron
  • Dzhenningz, Endryu Stefen Robert
  • Kridlend, Endryu Piter
  • Kharli, Kristofer
RU2637944C2
SUBSTITUTED DERIVATIVES OF ISOTHIAZOLE-PYRIDONE-AZETIDYL AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS 1991
  • Ogjusto Kolombo Pinol'[Es]
  • Khordi Frigola Konstansa[Es]
  • Khuan Pares Korominas[Es]
RU2041226C1
SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY 2001
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Vej Dzhianmej
RU2278863C2
NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME 2014
  • Le-Tiran Arno
  • Le-Digarer Terri
  • Stark Zherom-Benua
  • Anlen Zhan-Mishel
  • Gijuzi Anne-Fransua
  • De-Nantej Gijom
  • Zhenes Olive
  • Dejvidson Dzhejms Eduard Pol
  • Marri Dzhejms Bruk
  • Chen Itszen
RU2617682C2
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1992
  • Dzhon Vatson Ehllingboj
  • Madelen Nikajdo
  • Zhak Framros Bazhli
RU2113437C1
ESTROGEN RECEPTOR MODULATORS 2017
  • Khuan Piter Tsinkhua
  • Sli Debora Khelen
  • Khegde Saji Gadzhanan
  • Khopkins Chad Deniel
  • Banker Kevin Duejn
  • Pinchman Dzhozef Robert
  • Sit Rakesh Kumar
RU2738646C2

RU 2 267 490 C2

Authors

Sui Zikhua

Makajlehg Mark Dzh.

Guan Dzhikhua

Dzhiang Vejkvin

Lehnter Dzhejms K.

Dates

2006-01-10Published

2001-05-03Filed